Literature DB >> 19154952

Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.

Josina M Rijkelijkhuizen1, Teddo Doesburg, Cynthia J Girman, Andrea Mari, Thomas Rhodes, Amalia Gastaldelli, Giel Nijpels, Jacqueline M Dekker.   

Abstract

We evaluated the association of hepatic fat with beta-cell function estimated from the oral glucose tolerance test. In addition, we tested the hypothesis that postprandial free fatty acid (FFA) suppression after a meal tolerance test (MTT) is linked to hepatic fat. Individuals with normal glucose metabolism (NGM; n = 10 with low and n = 10 with high insulin secretion, matched for insulin sensitivity and sex), impaired glucose metabolism (IGM; n = 14), and type 2 diabetes mellitus (DM; n = 14) underwent a 75-g oral glucose tolerance test and MTT. beta-Cell function estimates were calculated from C-peptide using a mathematical model. Liver fat was quantified by proton magnetic resonance ((1)H-MR) spectroscopy. Area under the curve (AUC) of triglycerides (TG) and FFA responses during MTT represented postprandial lipid responses. Linear regression models were adjusted for age, sex, and additionally for insulin sensitivity for IGM/DM subjects. Liver fat content was equal for the NGM groups with low and high insulin secretion: 4.5% (2.6-6.0) (median, interquartile range) and 4.9% (2.3-7.8), respectively; liver fat percentages of IGM and diabetic subjects were significantly higher: 11.2 (6.7-21.1) and 10.0 (7.8-24.5). Liver fat showed a fairly strong, significant negative association with insulin sensitivity, but was not associated with beta-cell function. Significant associations of liver fat with fasting TG and AUC(TG) were shown in the total study population and in IGM/DM subjects separately. No relationship existed between fasting FFA or AUC(FFA) and liver fat. We conclude that fat accumulation in the liver is tightly linked to insulin sensitivity but not to beta-cell function. Furthermore, liver fat is associated with circulating TG levels, but not with FFA concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154952     DOI: 10.1016/j.metabol.2008.09.013

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  The impact of liver fat vs visceral fat in determining categories of prediabetes.

Authors:  K Kantartzis; J Machann; F Schick; A Fritsche; H-U Häring; N Stefan
Journal:  Diabetologia       Date:  2010-01-23       Impact factor: 10.122

2.  Trans fatty acid-induced NF-kappaB activation does not induce insulin resistance in cultured murine skeletal muscle cells.

Authors:  Pascal P H Hommelberg; Ramon C J Langen; Annemie M W J Schols; Anon L M van Essen; Frank J M Snepvangers; Ronald P Mensink; Jogchum Plat
Journal:  Lipids       Date:  2010-02-09       Impact factor: 1.880

3.  Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women.

Authors:  Giorgio Bedogni; Amalia Gastaldelli; Claudio Tiribelli; Fiorenza Agosti; Alessandra De Col; Rezene Fessehatsion; Alessandro Sartorio
Journal:  J Endocrinol Invest       Date:  2014-06-07       Impact factor: 4.256

4.  Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice.

Authors:  Deng Ping Yin; Qiang Gao; Lian Li Ma; Wenwei Yan; Phillip E Williams; Owen P McGuinness; David H Wasserman; Naji N Abumrad
Journal:  Ann Surg       Date:  2011-07       Impact factor: 12.969

5.  Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.

Authors:  Ebe D'Adamo; Anna M G Cali; Ram Weiss; Nicola Santoro; Bridget Pierpont; Veronika Northrup; Sonia Caprio
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

6.  Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.

Authors:  Laura G Sánchez-Lozada; Wei Mu; Carlos Roncal; Yuri Y Sautin; Manal Abdelmalek; Sirirat Reungjui; MyPhuong Le; Takahiko Nakagawa; Hui Y Lan; Xuequing Yu; Richard J Johnson
Journal:  Eur J Nutr       Date:  2009-07-22       Impact factor: 5.614

7.  Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women.

Authors:  Kristina M Utzschneider; Anna Largajolli; Alessandra Bertoldo; Santica Marcovina; James E Nelson; Matthew M Yeh; Kris V Kowdley; Steven E Kahn
Journal:  J Diabetes Complications       Date:  2013-11-26       Impact factor: 2.852

8.  Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.

Authors:  Gautam K Singh; Bernadette E Vitola; Mark R Holland; Timothy Sekarski; Bruce W Patterson; Faidon Magkos; Samuel Klein
Journal:  J Pediatr       Date:  2012-12-20       Impact factor: 4.406

9.  Liver Fat Reduction After Gastric Banding and Associations with Changes in Insulin Sensitivity and β-Cell Function.

Authors:  Anny H Xiang; Mayra P Martinez; Enrique Trigo; Kristina M Utzschneider; Melanie Cree-Green; Silva A Arslanian; David A Ehrmann; Sonia Caprio; Passant H I H Mohamed; Darryl H Hwang; Namir Katkhouda; Krishna S Nayak; Thomas A Buchanan
Journal:  Obesity (Silver Spring)       Date:  2021-05-26       Impact factor: 9.298

10.  Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.

Authors:  Lisa B VanWagner; Hongyan Ning; Norrina B Allen; Juned Siddique; April P Carson; Michael P Bancks; Cora E Lewis; John Jeffrey Carr; Elizabeth Speliotes; Norah A Terrault; Mary E Rinella; Miriam B Vos; Donald M Lloyd-Jones
Journal:  Liver Int       Date:  2018-04-24       Impact factor: 8.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.